Company Filing History:
Years Active: 2024-2025
Title: Bin Jiang: Innovator in Pharmaceutical and Digital Asset Technologies
Introduction
Bin Jiang is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of pharmaceuticals and digital asset management. With a total of 2 patents, his work focuses on innovative solutions that address critical challenges in these areas.
Latest Patents
One of Bin Jiang's latest patents is titled "PRMT5 inhibiting compounds and uses thereof." This application provides novel PRMT5 and/or MTA-cooperative PRMT5 inhibiting compounds, along with their pharmaceutically acceptable salts. The patent also outlines pharmaceutical compositions that include these compounds as active ingredients, emphasizing their potential use in treating various diseases, including cancers.
Another significant patent is "Method for performing segmenting locking and merging control of encrypted digital assets based on time dimension." This method aims to enhance the control of encrypted digital assets by incorporating a time attribute. It allows for automated transfers of these assets using smart contracts or hash locking, ensuring deterministic payments of future value rights and broadening the range of applications.
Career Highlights
Throughout his career, Bin Jiang has worked with notable companies, including Antengene Discovery Limited and Shanghai Jianwei Zhizhu Enterprise Management Center. His experience in these organizations has contributed to his expertise in developing innovative solutions in his fields of interest.
Collaborations
Bin Jiang has collaborated with several professionals, including Ming Zhang and Ya Kong. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Bin Jiang is a distinguished inventor whose work in pharmaceuticals and digital asset technologies showcases his innovative spirit. His patents reflect a commitment to addressing complex challenges in these fields, making him a valuable contributor to the world of innovation.